Logo image of 1EXPE.MI

EXPEDIA GROUP INC (1EXPE.MI) Stock Fundamental Analysis

BIT:1EXPE - Euronext Milan - US30212P3038 - Common Stock - Currency: EUR

188.4  -4.98 (-2.58%)

Fundamental Rating

5

Overall 1EXPE gets a fundamental rating of 5 out of 10. We evaluated 1EXPE against 54 industry peers in the Hotels, Restaurants & Leisure industry. 1EXPE has an excellent profitability rating, but there are concerns on its financial health. 1EXPE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

1EXPE had positive earnings in the past year.
1EXPE had a positive operating cash flow in the past year.
In multiple years 1EXPE reported negative net income over the last 5 years.
Of the past 5 years 1EXPE 4 years had a positive operating cash flow.
1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCF1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

With a decent Return On Assets value of 5.49%, 1EXPE is doing good in the industry, outperforming 69.09% of the companies in the same industry.
The Return On Equity of 1EXPE (78.87%) is better than 96.36% of its industry peers.
1EXPE's Return On Invested Capital of 13.93% is fine compared to the rest of the industry. 1EXPE outperforms 78.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1EXPE is in line with the industry average of 11.61%.
The 3 year average ROIC (10.99%) for 1EXPE is below the current ROIC(13.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.49%
ROE 78.87%
ROIC 13.93%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
1EXPE.MI Yearly ROA, ROE, ROIC1EXPE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

With a decent Profit Margin value of 8.97%, 1EXPE is doing good in the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Profit Margin of 1EXPE has grown nicely.
The Operating Margin of 1EXPE (12.15%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 1EXPE has grown nicely.
Looking at the Gross Margin, with a value of 89.44%, 1EXPE belongs to the top of the industry, outperforming 89.09% of the companies in the same industry.
1EXPE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.15%
PM (TTM) 8.97%
GM 89.44%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
1EXPE.MI Yearly Profit, Operating, Gross Margins1EXPE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1EXPE is still creating some value.
Compared to 1 year ago, 1EXPE has less shares outstanding
Compared to 5 years ago, 1EXPE has less shares outstanding
1EXPE has a better debt/assets ratio than last year.
1EXPE.MI Yearly Shares Outstanding1EXPE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1EXPE.MI Yearly Total Debt VS Total Assets1EXPE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

1EXPE has an Altman-Z score of 1.45. This is a bad value and indicates that 1EXPE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.45, 1EXPE is in line with its industry, outperforming 49.09% of the companies in the same industry.
1EXPE has a debt to FCF ratio of 2.69. This is a good value and a sign of high solvency as 1EXPE would need 2.69 years to pay back of all of its debts.
1EXPE's Debt to FCF ratio of 2.69 is fine compared to the rest of the industry. 1EXPE outperforms 76.36% of its industry peers.
A Debt/Equity ratio of 3.35 is on the high side and indicates that 1EXPE has dependencies on debt financing.
1EXPE's Debt to Equity ratio of 3.35 is on the low side compared to the rest of the industry. 1EXPE is outperformed by 61.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF 2.69
Altman-Z 1.45
ROIC/WACC1.68
WACC8.31%
1EXPE.MI Yearly LT Debt VS Equity VS FCF1EXPE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.72 indicates that 1EXPE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.72, 1EXPE is doing worse than 65.45% of the companies in the same industry.
1EXPE has a Quick Ratio of 0.72. This is a bad value and indicates that 1EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
1EXPE's Quick ratio of 0.72 is on the low side compared to the rest of the industry. 1EXPE is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
1EXPE.MI Yearly Current Assets VS Current Liabilites1EXPE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.64% over the past year.
1EXPE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.87% yearly.
Looking at the last year, 1EXPE shows a small growth in Revenue. The Revenue has grown by 6.64% in the last year.
The Revenue has been growing slightly by 2.56% on average over the past years.
EPS 1Y (TTM)24.64%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%38.95%
Revenue 1Y (TTM)6.64%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%10.29%

3.2 Future

1EXPE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.71% yearly.
1EXPE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.45% yearly.
EPS Next Y18.93%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
EPS Next 5Y16.71%
Revenue Next Year6.61%
Revenue Next 2Y6.83%
Revenue Next 3Y7.06%
Revenue Next 5Y6.45%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1EXPE.MI Yearly Revenue VS Estimates1EXPE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1EXPE.MI Yearly EPS VS Estimates1EXPE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.76, the valuation of 1EXPE can be described as correct.
Based on the Price/Earnings ratio, 1EXPE is valued a bit cheaper than 76.36% of the companies in the same industry.
1EXPE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.99.
The Price/Forward Earnings ratio is 14.09, which indicates a correct valuation of 1EXPE.
74.55% of the companies in the same industry are more expensive than 1EXPE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of 1EXPE to the average of the S&P500 Index (20.35), we can say 1EXPE is valued slightly cheaper.
Industry RankSector Rank
PE 16.76
Fwd PE 14.09
1EXPE.MI Price Earnings VS Forward Price Earnings1EXPE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

1EXPE's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, 1EXPE is valued a bit cheaper than the industry average as 69.09% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.35
EV/EBITDA 11.16
1EXPE.MI Per share data1EXPE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1EXPE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1EXPE's earnings are expected to grow with 17.50% in the coming years.
PEG (NY)0.89
PEG (5Y)1.13
EPS Next 2Y18.99%
EPS Next 3Y17.5%

2

5. Dividend

5.1 Amount

1EXPE has a Yearly Dividend Yield of 1.02%. Purely for dividend investing, there may be better candidates out there.
1EXPE's Dividend Yield is a higher than the industry average which is at 3.10.
With a Dividend Yield of 1.02, 1EXPE pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DP0%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
1EXPE.MI Yearly Income VS Free CF VS Dividend1EXPE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

BIT:1EXPE (3/3/2025, 7:00:00 PM)

188.4

-4.98 (-2.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners97.28%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap24.28B
Analysts72.56
Price Target205.47 (9.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.08%
Min EPS beat(2)-0.95%
Max EPS beat(2)15.12%
EPS beat(4)3
Avg EPS beat(4)53.42%
Min EPS beat(4)-0.95%
Max EPS beat(4)187.08%
EPS beat(8)6
Avg EPS beat(8)-17.83%
EPS beat(12)8
Avg EPS beat(12)-10.27%
EPS beat(16)11
Avg EPS beat(16)-1.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.78%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)1.66%
Revenue beat(8)2
Avg Revenue beat(8)-0.98%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)0.33%
PT rev (1m)8%
PT rev (3m)33.1%
EPS NQ rev (1m)88.97%
EPS NQ rev (3m)702.93%
EPS NY rev (1m)0.98%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)-1.75%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-1.22%
Revenue NY rev (3m)-5.14%
Valuation
Industry RankSector Rank
PE 16.76
Fwd PE 14.09
P/S 1.93
P/FCF 11.35
P/OCF 8.57
P/B 16.98
P/tB N/A
EV/EBITDA 11.16
EPS(TTM)11.24
EY5.97%
EPS(NY)13.37
Fwd EY7.1%
FCF(TTM)16.6
FCFY8.81%
OCF(TTM)21.99
OCFY11.67%
SpS97.57
BVpS11.1
TBVpS-43.5
PEG (NY)0.89
PEG (5Y)1.13
Profitability
Industry RankSector Rank
ROA 5.49%
ROE 78.87%
ROCE 18.96%
ROIC 13.93%
ROICexc 28.48%
ROICexgc N/A
OM 12.15%
PM (TTM) 8.97%
GM 89.44%
FCFM 17.01%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score8
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF 2.69
Debt/EBITDA 2.09
Cap/Depr 90.21%
Cap/Sales 5.52%
Interest Coverage 7.2
Cash Conversion 123.3%
Profit Quality 189.66%
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 1.45
F-Score8
WACC8.31%
ROIC/WACC1.68
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.64%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%38.95%
EPS Next Y18.93%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
EPS Next 5Y16.71%
Revenue 1Y (TTM)6.64%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%10.29%
Revenue Next Year6.61%
Revenue Next 2Y6.83%
Revenue Next 3Y7.06%
Revenue Next 5Y6.45%
EBIT growth 1Y13.43%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year133.26%
EBIT Next 3Y40.4%
EBIT Next 5Y26.87%
FCF growth 1Y26.3%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y14.68%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%